Free Trial

Howard Hughes (HHH) Competitors

Howard Hughes logo
$81.89 +0.34 (+0.41%)
Closing price 03:59 PM Eastern
Extended Trading
$82.00 +0.11 (+0.14%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HHH vs. TSHA, ZG, WPC, HLI, GLPI, REG, JEF, AMH, DOC, and HST

Should you be buying Howard Hughes stock or one of its competitors? The main competitors of Howard Hughes include Taysha Gene Therapies (TSHA), Zillow Group (ZG), W.P. Carey (WPC), Houlihan Lokey (HLI), Gaming and Leisure Properties (GLPI), Regency Centers (REG), Jefferies Financial Group (JEF), American Homes 4 Rent (AMH), Healthpeak Properties (DOC), and Host Hotels & Resorts (HST).

Howard Hughes vs. Its Competitors

Howard Hughes (NYSE:HHH) and Taysha Gene Therapies (NASDAQ:TSHA) are related companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

Howard Hughes has higher revenue and earnings than Taysha Gene Therapies. Taysha Gene Therapies is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Howard Hughes$1.75B2.78$200.55M$4.5717.92
Taysha Gene Therapies$8.33M98.90-$89.30M-$0.34-8.88

Howard Hughes has a net margin of 12.85% compared to Taysha Gene Therapies' net margin of -1,144.97%. Howard Hughes' return on equity of 10.51% beat Taysha Gene Therapies' return on equity.

Company Net Margins Return on Equity Return on Assets
Howard Hughes12.85% 10.51% 3.15%
Taysha Gene Therapies -1,144.97%-78.44%-44.82%

Howard Hughes currently has a consensus price target of $83.33, suggesting a potential upside of 1.77%. Taysha Gene Therapies has a consensus price target of $8.29, suggesting a potential upside of 174.36%. Given Taysha Gene Therapies' stronger consensus rating and higher probable upside, analysts clearly believe Taysha Gene Therapies is more favorable than Howard Hughes.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Howard Hughes
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Taysha Gene Therapies
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
3.00

Howard Hughes has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. Comparatively, Taysha Gene Therapies has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500.

In the previous week, Howard Hughes had 2 more articles in the media than Taysha Gene Therapies. MarketBeat recorded 8 mentions for Howard Hughes and 6 mentions for Taysha Gene Therapies. Howard Hughes' average media sentiment score of 1.69 beat Taysha Gene Therapies' score of 1.17 indicating that Howard Hughes is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Howard Hughes
8 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Taysha Gene Therapies
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

93.8% of Howard Hughes shares are held by institutional investors. Comparatively, 77.7% of Taysha Gene Therapies shares are held by institutional investors. 48.0% of Howard Hughes shares are held by company insiders. Comparatively, 3.8% of Taysha Gene Therapies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Howard Hughes beats Taysha Gene Therapies on 12 of the 16 factors compared between the two stocks.

Get Howard Hughes News Delivered to You Automatically

Sign up to receive the latest news and ratings for HHH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HHH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HHH vs. The Competition

MetricHoward HughesREAL ESTATE DEV IndustryFinance SectorNYSE Exchange
Market Cap$4.84B$2.99B$12.73B$21.53B
Dividend YieldN/A2.45%5.42%3.50%
P/E Ratio17.9211.46244.6429.84
Price / Sales2.783.7830.9752.61
Price / Cash8.4228.4219.2518.13
Price / Book1.451.082.314.65
Net Income$200.55M-$97.03M$1.01B$999.94M
7 Day Performance3.70%0.52%0.66%0.79%
1 Month Performance11.08%4.36%3.19%4.54%
1 Year Performance8.18%9.48%543.58%16.77%

Howard Hughes Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HHH
Howard Hughes
2.3565 of 5 stars
$81.89
+0.4%
$83.33
+1.8%
+7.8%$4.84B$1.75B17.92608Positive News
TSHA
Taysha Gene Therapies
2.4656 of 5 stars
$3.24
-3.6%
$8.29
+155.7%
+34.1%$916.59M$8.33M-9.53180Insider Trade
ZG
Zillow Group
3.8625 of 5 stars
$86.53
+2.1%
$85.62
-1.1%
+45.8%$20.54B$2.24B-332.816,856
WPC
W.P. Carey
3.5386 of 5 stars
$67.38
-1.1%
$66.33
-1.5%
+8.5%$14.92B$1.58B44.33190News Coverage
Positive News
Analyst Forecast
HLI
Houlihan Lokey
4.9095 of 5 stars
$198.65
+0.8%
$210.60
+6.0%
+33.2%$13.86B$2.39B33.441,100Positive News
GLPI
Gaming and Leisure Properties
4.6831 of 5 stars
$47.93
-1.0%
$52.69
+9.9%
-6.9%$13.71B$1.57B18.5820Positive News
Ex-Dividend
REG
Regency Centers
4.3751 of 5 stars
$73.08
-0.8%
$79.00
+8.1%
-4.5%$13.38B$1.45B34.15440News Coverage
Positive News
Analyst Forecast
JEF
Jefferies Financial Group
4.6527 of 5 stars
$64.18
+1.1%
$70.50
+9.8%
+13.9%$13.10B$7.03B24.227,822
AMH
American Homes 4 Rent
4.8664 of 5 stars
$34.71
-0.4%
$40.42
+16.5%
-17.0%$12.93B$1.73B31.271,730Positive News
Analyst Forecast
DOC
Healthpeak Properties
4.9249 of 5 stars
$18.32
-0.4%
$21.50
+17.4%
-19.8%$12.78B$543.46M76.32200News Coverage
Positive News
Analyst Upgrade
HST
Host Hotels & Resorts
3.9895 of 5 stars
$17.39
-0.2%
$17.77
+2.2%
+1.0%$11.98B$5.68B18.50160News Coverage
Positive News
Dividend Announcement

Related Companies and Tools


This page (NYSE:HHH) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners